Cargando…
Heavy Menstrual Bleeding Treatment With a Levonorgestrel 52-mg Intrauterine Device
To evaluate heavy menstrual bleeding treatment outcomes with levonorgestrel 52-mg intrauterine device (IUD) use in participants without body mass index (BMI) or parity restrictions. METHODS: Investigators included participants aged 18–50 years with no pelvic or systemic pathology causing heavy menst...
Autores principales: | Creinin, Mitchell D., Barnhart, Kurt T., Gawron, Lori M., Eisenberg, David, Mabey, R. Garn, Jensen, Jeffrey T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10108838/ https://www.ncbi.nlm.nih.gov/pubmed/37023455 http://dx.doi.org/10.1097/AOG.0000000000005137 |
Ejemplares similares
-
Comparison of Bleeding Pattern and Quality of Life Before and After the Insertion of a Levonorgestrel Intrauterine System for Heavy Menstrual Bleeding: A Seven-Year Review
por: Agarwal, Mukta, et al.
Publicado: (2023) -
Five-Year Contraceptive Efficacy and Safety of a Levonorgestrel 52-mg Intrauterine System
por: Teal, Stephanie B., et al.
Publicado: (2019) -
Levonorgestrel intrauterine system: Current role in management of heavy menstrual bleeding
por: Magon, Navneet, et al.
Publicado: (2013) -
Consecutive Use of the 52 mg Levonorgestrel-releasing Intrauterine System: Variations in Bleeding Patterns
por: Wittmann, Barbara Zantut, et al.
Publicado: (2020) -
Predictive factors for failure of the levonorgestrel releasing intrauterine system in women with heavy menstrual bleeding
por: Beelen, Pleun, et al.
Publicado: (2021)